Tech Company Financing Transactions
Akriveia Therapeutics Funding Round
F-Prime Capital and private investors invested in a $7.5 million Series A funding round for Akriveia Therapeutics. The round was announced on 10/13/2016.
Transaction Overview
Company Name
Announced On
10/13/2016
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Series A
Investors
F-Prime Capital (Benjamin Auspitz)
Proceeds Purpose
The financing will help us attract talented leaders and innovators to drive our therapeutic discovery efforts, and to build a pipeline of best-in-class single agent and combination immunotherapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
23 Southern Hills Dr.
Skillman, NJ 08558
USA
Skillman, NJ 08558
USA
Phone
Email Address
Not Recorded
Overview
Akriveia Therapeutics, LLC operates as a biotechnology company. The company was incorporated in 2015 and is based in Skillman, New Jersey.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simon Tomlinson
Browse more venture capital transactions:
Prev: 10/13/2016: FourKites venture capital transaction
Next: 10/14/2016: TrackR venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs